封面
市场调查报告书
商品编码
1986621

全球医药玻璃包装市场:市场规模、份额和趋势分析(按材料、产品、药品和地区划分),细分市场预测(2026-2033 年)

Pharmaceutical Glass Packaging Market Size, Share & Trends Analysis Report By Material (Type I, Type II, Type III), By Product (Vials, Bottles, Ampoules), By Drug (Generic, Branded, Biologic), By Region, And Segment Forecasts, 2026 - 2033

出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

医药玻璃包装市场概况

2025年全球医药玻璃包装市场规模估计为234亿美元,预计2033年将达到515.6亿美元。

预计从 2026 年到 2033 年,该市场将以 10.5% 的复合年增长率成长。非专利注射剂的广泛使用,加上製药业的强劲需求,预计将推动市场成长。

玻璃的主要化学成分包括石灰石(CaCO₃)、碱灰(Na₂CO₃)、玻璃屑和沙子(SiO₂)。在医药包装应用中,玻璃製品中最常见的阳离子是钡、锌、铁、镁、钙、钾、钠、硼、铝和硅。这些物质会影响玻璃的性能,例如耐化学性、硬度和耐久性。

随着医疗领域成本意识的增强和生物製药重要性的日益凸显,针对药物输送产品的监管也日益严格。许多製药玻璃製品生产商正致力于研发能够延长产品保质期的包装,因此加大了对管瓶的投入。

为药品开发玻璃包装的公司正致力于提升产品功能,以适应不断发展的製药业,预计将进一步推动美国市场成长。例如,康宁公司于2023年11月推出了采用特殊涂层设计的I型硼硅酸管瓶,名为「康宁Velocity 管瓶 」。与传统的硼硅酸管瓶相比,这种管瓶硬度更高,从而降低了开裂或破损的可能性。

玻璃起到阻隔作用,防止二氧化碳和氧气等大气气体进入药品的玻璃容器,降低污染风险。玻璃包装还能降低药品发生水解和氧化等劣化的几率。此外,玻璃包装有助于防止挥发性成分逸出,进而提高药品的稳定性。所有这些因素都表明,预计未来一段时间内,药品需求将大幅成长。

医药玻璃包装产业正经历显着成长,并保持着强劲的创新势头。除了可回收的特性外,玻璃包装也因其永续性和环保包装解决方案日益受到业内人士的关注而成为极具吸引力的选择,这与製药公司对永续发展的承诺不谋而合。整合RFID标籤和防篡改功能等智慧包装技术,进一步提升了医药玻璃包装的吸引力和实用性。能够提供符合药品包装日益严格法规的创新、合规且经济高效的玻璃包装解决方案的製造商,将有望获得可观的市场份额。

目录

第一章:分析方法和范围

第二章执行摘要

第三章:全球医药玻璃包装市场:影响因素、趋势与范围

  • 市场历史及展望
    • 母市场展望
  • 产业价值链分析
    • 原料趋势
    • 製造业/科技趋势
    • 销售管道分析
  • 法律规范
  • 市场动态
  • 商业环境分析
    • 波特五力分析
    • PESTEL 分析
  • 环境、社会与管治(ESG)倡议对医药玻璃包装市场的影响
    • 市场差异化
    • 监理合规
    • 产业合作
    • 提升品牌价值
    • 回应消费者需求

第四章:医药玻璃包装市场:价格趋势分析

  • 价格趋势分析:依材料分类(2021-2033 年)
  • 影响价格波动的因素

第五章:医药玻璃包装市场:依材料分類的估算与趋势分析

  • 波动分析及市场份额:按材料分类(2025-2033 年)
  • 一型
  • II 型
  • III型

第六章:医药玻璃包装市场:依产品类别分類的估价与趋势分析

  • 波动分析及市场份额:按产品划分(2025-2033 年)
  • 管瓶
  • 瓶子
  • 墨水匣和注射器
  • 安瓿

第七章:医药玻璃包装市场:依药品类型分類的估价与趋势分析

  • 波动分析及市场份额:按药品类型划分(2025 年和 2033 年)
  • 非专利的
  • 品牌药品
  • 生物製药

第八章:医药玻璃包装市场:区域估算与趋势分析

  • 波动分析及市场份额:按材料分类(2025-2033 年)
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 西班牙
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
  • 中美洲和南美洲
    • 巴西
  • 中东和非洲
    • 沙乌地阿拉伯

第九章 竞争情势

  • 主要企业:最新趋势与产业影响
  • 主要企业/竞争对手分类(主要创新者、市场领导、新兴企业)
  • 主要原料经销商和通路伙伴名单
  • 潜在客户名单:按最终用户分类
  • 企业热力图分析
  • 竞争对手仪錶板分析
  • 策略规划
    • 扩大产能
    • 伙伴关係与协议
    • 新产品发布
    • 企业合併(M&A)
    • 技术和材料创新
    • 其他的

第十章:上市公司名单/公司简介

  • Corning Incorporated
  • Nipro Corporation
  • SGD SA
  • Stolzle-Oberglas GmbH
  • West Pharmaceutical Services, Inc.
  • Schott AG
  • Gerresheimer AG
  • Bormioli Pharma Srl
  • Shandong Medicinal Glass Co., Ltd.
  • Beatson Clark
  • Ardagh Group SA
  • Arab Pharmaceutical Glass Co.
  • Piramal Enterprises Ltd.
  • Sisecam Group
  • Owens-Illinois, Inc
  • DWK Life Sciences
Product Code: GVR-2-68038-175-7

Pharmaceutical Glass Packaging Market Summary

The global pharmaceutical glass packaging market size was estimated at USD 23.40 billion in 2025 and is projected to reach USD 51.56 billion by 2033, growing at a CAGR of 10.5% from 2026 to 2033. Extensive utilization of generic injectable drugs coupled with high demand from the pharmaceutical industry is anticipated to drive market growth.

Limestone (CaCO3), soda ash (Na2CO3), cullet, and sand (SiO2) comprise the overall chemical composition of glass. For pharmaceutical packaging applications, the most common cations found in glassware are barium, zinc, ferrous, magnesium, calcium, potassium, sodium, boron, aluminum, and silicon. These materials influence the properties of glass such as chemical resistance, hardness, and durability.

The growing significance of cost-sensitivity and biotech drugs in the healthcare sector has resulted in the establishment of strict regulations related to the drug delivery products. Multiple manufacturers working in pharmaceutical glass manufacturing industry are focused on packaging aimed at increasing shelf life of a product and are therefore investing in vials.

Pharmaceutical glass packaging developers have been enhancing their product capabilities to cater to the changing pharmaceutical industry, which can further contribute to the market growth in the U.S. For instance, in November 2023, Corning Incorporated introduced coated specially engineered Type I borosilicate vials known as Corning Velocity Vials. These vials exhibit effective hardness compared to conventional borosilicate vials, reducing the probability of cracking and breaking.

Glass poses as a hindrance to atmospheric gases such as carbon dioxide and oxygen from entering the primary pharmaceutical glass container, mitigating the risk of contamination of the drugs. Glass packaging lowers the susceptibility of drugs to degradation, such as hydrolysis and oxidation. Moreover, glass packaging helps in resisting escape of volatile ingredients, thereby increasing the drug stability. All these factors are anticipated to surge the product demand in near future.

The pharmaceutical glass packaging industry is poised for significant growth and innovation. Given its recyclable nature, the industry's increasing focus on sustainability and environmentally friendly packaging solutions positions glass as an attractive choice, which aligns well with pharmaceutical companies' heightened emphasis on sustainable practices. Integrating intelligent packaging technologies, such as RFID tags and tamper-evident features, enhances the appeal and functionality of pharmaceutical glass packaging. In response to tightening regulations on pharmaceutical packaging, manufacturers that offer inventive, compliant, and cost-effective glass packaging solutions are well-positioned to capture substantial market share.

Global Pharmaceutical Glass Packaging Market Report Segmentation

This report forecasts revenue growth at a global level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pharmaceutical glass packaging market report based on material, product, drug, material, and region:

  • Material Outlook (Volume, Million Units; Revenue, USD Million, 2021 - 2033)
  • Type I
  • Type II
  • Type III
  • Product Outlook (Volume, Million Units; Revenue, USD Million, 2021 - 2033)
  • Vials
    • Small vials
    • Large vials
  • Bottles
    • Small bottles
    • Large bottles
  • Cartridges & Syringes
  • Ampoules
  • Drug Outlook (Volume, Million Units; Revenue, USD Million, 2021 - 2033)
  • Generic
  • Branded
  • Biologic
  • Regional Outlook (Volume, Million Units; Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Latin America
    • Brazil
  • Middle East & Africa
    • Saudi Arabia

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Research Methodology
    • 1.1.1. Market Segmentation
    • 1.1.2. Market Definition
  • 1.2. Research Scope & Assumptions
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot, 2024 (USD Million)
  • 2.2. Segmental Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Global Pharmaceutical Glass Packaging Market Variables, Trends, and Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Marke Outlook
  • 3.2. Industry Value Chain Analysis
    • 3.2.1. Raw Material Trends
    • 3.2.2. Manufacturing/Technology Trends
    • 3.2.3. Sales Channel Analysis
  • 3.3. Regulatory Framework
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
    • 3.4.2. Market Restraint Analysis
    • 3.4.3. Market Opportunity Analysis
    • 3.4.4. Market Challenge Analysis
  • 3.5. Business Environment Analysis
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. PESTEL Analysis
  • 3.6. Impact of Environmental, Social, and Governance (ESG) initiatives on the Pharmaceutical Glass Packaging Market
    • 3.6.1. Market Differentiation
    • 3.6.2. Regulatory Compliance
    • 3.6.3. Industry Collaboration
    • 3.6.4. Enhanced Brand Value
    • 3.6.5. Addressing Consumer Demands

Chapter 4. Pharmaceutical Glass Packaging Market: Price Trend Analysis

  • 4.1. Pricing Trend Analysis, by Material, 2021 - 2033 (USD/Units)
  • 4.2. Factors Affecting the Pricing Deviation

Chapter 5. Pharmaceutical Glass Packaging Market: Material Estimates & Trend Analysis

  • 5.1. Definition & Scope
  • 5.2. Material Movement Analysis & Market Share, 2025 & 2033
  • 5.3. Type I
    • 5.3.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
  • 5.4. Type II
    • 5.4.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
  • 5.5. Type III
    • 5.5.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)

Chapter 6. Pharmaceutical Glass Packaging Market: Product Estimates & Trend Analysis

  • 6.1. Definition & Scope
  • 6.2. Product Movement Analysis & Market Share, 2025 & 2033
  • 6.3. Vials
    • 6.3.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
  • 6.4. Bottles
    • 6.4.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
  • 6.5. Cartridges & Syringes
    • 6.5.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
  • 6.6. Ampoules
    • 6.6.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)

Chapter 7. Pharmaceutical Glass Packaging Market: Drug Estimates & Trend Analysis

  • 7.1. Definition & Scope
  • 7.2. Drug Movement Analysis & Market Share, 2025 & 2033
  • 7.3. Generic
    • 7.3.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
  • 7.4. Branded
    • 7.4.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
  • 7.5. Biologic
    • 7.5.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)

Chapter 8. Pharmaceutical Glass Packaging Market: Regional Estimates & Trend Analysis

  • 8.1. Key Takeaways
  • 8.2. Regional Movement Analysis & Market Share, 2025 & 2033
  • 8.3. North America
    • 8.3.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
    • 8.3.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
    • 8.3.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
    • 8.3.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
    • 8.3.5. U.S.
      • 8.3.5.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
      • 8.3.5.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
      • 8.3.5.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
      • 8.3.5.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
    • 8.3.6. Canada
      • 8.3.6.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
      • 8.3.6.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
      • 8.3.6.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
      • 8.3.6.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
    • 8.3.7. Mexico
      • 8.3.7.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
      • 8.3.7.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
      • 8.3.7.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
      • 8.3.7.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
  • 8.4. Europe
    • 8.4.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
    • 8.4.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
    • 8.4.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
    • 8.4.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
    • 8.4.5. Germany
      • 8.4.5.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
      • 8.4.5.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
      • 8.4.5.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
      • 8.4.5.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
    • 8.4.6. UK
      • 8.4.6.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
      • 8.4.6.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
      • 8.4.6.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
      • 8.4.6.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
    • 8.4.7. Italy
      • 8.4.7.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
      • 8.4.7.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
      • 8.4.7.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
      • 8.4.7.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
    • 8.4.8. Spain
      • 8.4.8.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
      • 8.4.8.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
      • 8.4.8.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
      • 8.4.8.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
    • 8.5.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
    • 8.5.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
    • 8.5.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
    • 8.5.5. China
      • 8.5.5.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
      • 8.5.5.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
      • 8.5.5.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
      • 8.5.5.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
    • 8.5.6. India
      • 8.5.6.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
      • 8.5.6.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
      • 8.5.6.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
      • 8.5.6.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
    • 8.5.7. Japan
      • 8.5.7.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
      • 8.5.7.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
      • 8.5.7.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
      • 8.5.7.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
    • 8.5.8. South Korea
      • 8.5.8.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
      • 8.5.8.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
      • 8.5.8.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
      • 8.5.8.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
    • 8.5.9. Australia
      • 8.5.9.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
      • 8.5.9.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
      • 8.5.9.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
      • 8.5.9.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
  • 8.6. Central & South America
    • 8.6.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
    • 8.6.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
    • 8.6.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
    • 8.6.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
    • 8.6.5. Brazil
      • 8.6.5.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
      • 8.6.5.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
      • 8.6.5.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
      • 8.6.5.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
  • 8.7. Middle East & Africa
    • 8.7.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
    • 8.7.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
    • 8.7.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
    • 8.7.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
    • 8.7.5. Saudi Arabia
      • 8.7.5.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
      • 8.7.5.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
      • 8.7.5.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
      • 8.7.5.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Key Global Players & Recent Developments & Their Impact On the Industry
  • 9.2. Key Company/Competition Categorization (Key innovators, Market leaders, emerging players)
  • 9.3. List of key Raw Material Distributors and Channel Partners
  • 9.4. List of Potential Customers, by End-use
  • 9.5. Company Heat Map Analysis
  • 9.6. Competitive Dashboard Analysis
  • 9.7. Strategy Mapping
    • 9.7.1. Capacity Expansion
    • 9.7.2. Collaboration/ Partnerships/ Agreements
    • 9.7.3. New Product launches
    • 9.7.4. Mergers & Acquisitions
    • 9.7.5. Innovation in Technology/ Material
    • 9.7.6. Others

Chapter 10. Company Listing / Profiles

  • 10.1. Corning Incorporated
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
  • 10.2. Nipro Corporation
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
  • 10.3. SGD S.A.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
  • 10.4. Stolzle-Oberglas GmbH
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
  • 10.5. West Pharmaceutical Services, Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
  • 10.6. Schott AG
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
  • 10.7. Gerresheimer AG
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
  • 10.8. Bormioli Pharma S.r.l
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
  • 10.9. Shandong Medicinal Glass Co., Ltd.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
  • 10.10. Beatson Clark
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
  • 10.11. Ardagh Group S.A.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
  • 10.12. Arab Pharmaceutical Glass Co.
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
  • 10.13. Piramal Enterprises Ltd.
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
  • 10.14. Sisecam Group
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
  • 10.15. Owens-Illinois, Inc
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
  • 10.16. DWK Life Sciences
    • 10.16.1. Company Overview
    • 10.16.2. Financial Performance
    • 10.16.3. Product Benchmarking

List of Tables

  • Table 1 Pharmaceutical Glass Packaging Market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
  • Table 2 Type I Pharmaceutical Glass Packaging Market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
  • Table 3 Type II Pharmaceutical Glass Packaging Market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
  • Table 4 Type III Pharmaceutical Glass Packaging Market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
  • Table 5 Pharmaceutical Glass Packaging Market estimates and forecasts, by vials, 2021 - 2033 (USD Million) (Million Units)
  • Table 6 Pharmaceutical Glass Packaging Market estimates and forecasts, by bottles, 2021 - 2033 (USD Million) (Million Units)
  • Table 7 Tertiary Pharmaceutical Glass Packaging Market estimates and forecasts, by cartridges & syringes, 2021 - 2033 (USD Million) (Million Units)
  • Table 8 Pharmaceutical Glass Packaging Market estimates and forecasts, by ampoules, 2021 - 2033 (USD Million) (Million Units)
  • Table 9 Pharmaceutical Glass Packaging Market estimates and forecasts, in generic, 2021 - 2033 (USD Million) (Million Units)
  • Table 10 Pharmaceutical Glass Packaging Market estimates and forecasts, in branded, 2021 - 2033 (USD Million) (Million Units)
  • Table 11 Pharmaceutical Glass Packaging Market estimates and forecasts, in biologic, 2021 - 2033 (USD Million) (Million Units)
  • Table 12 North America Pharmaceutical Glass Packaging Market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
  • Table 13 North America Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2021 - 2033 (USD Million) (Million Units)
  • Table 14 North America Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2021 - 2033 (USD Million) (Million Units)
  • Table 15 North America Pharmaceutical Glass Packaging Market estimates and forecasts, by drug, 2021 - 2033 (USD Million) (Million Units)
  • Table 16 U.S. Pharmaceutical Glass Packaging Market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
  • Table 17 U.S. Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2021 - 2033 (USD Million) (Million Units)
  • Table 18 U.S. Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2021 - 2033 (USD Million) (Million Units)
  • Table 19 U.S. Pharmaceutical Glass Packaging Market estimates and forecasts, by drug, 2021 - 2033 (USD Million) (Million Units)
  • Table 20 Canada Pharmaceutical Glass Packaging Market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
  • Table 21 Canada Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2021 - 2033 (USD Million) (Million Units)
  • Table 22 Canada Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2021 - 2033 (USD Million) (Million Units)
  • Table 23 Canada Pharmaceutical Glass Packaging Market estimates and forecasts, by Drug, 2021 - 2033 (USD Million) (Million Units)
  • Table 24 Mexico Pharmaceutical Glass Packaging Market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
  • Table 25 Mexico Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2021 - 2033 (USD Million)
  • Table 26 Mexico Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2021 - 2033 (Million Units)
  • Table 27 Mexico Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 28 Mexico Pharmaceutical Glass Packaging Market estimates and forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 29 Europe Pharmaceutical Glass Packaging Market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
  • Table 30 Europe Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2021 - 2033 (USD Million) (Million Units)
  • Table 31 Europe Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 32 Europe Pharmaceutical Glass Packaging Market estimates and forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 33 Germany Pharmaceutical Glass Packaging Market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
  • Table 34 Germany Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2021 - 2033 (USD Million) (Million Units)
  • Table 35 Germany Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2021 - 2033 (USD Million) (Million Units)
  • Table 36 Germany Pharmaceutical Glass Packaging Market estimates and forecasts, by Drug, 2021 - 2033 (USD Million) (Million Units)
  • Table 37 UK Pharmaceutical Glass Packaging Market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
  • Table 38 UK Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2021 - 2033 (USD Million) (Million Units)
  • Table 39 UK Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 40 UK Pharmaceutical Glass Packaging Market estimates and forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 41 France Pharmaceutical Glass Packaging Market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
  • Table 42 France Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2021 - 2033 (USD Million) (Million Units)
  • Table 43 France Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2021 - 2033 (USD Million) (Million Units)
  • Table 44 France Pharmaceutical Glass Packaging Market estimates and forecasts, by Drug, 2021 - 2033 (USD Million) (Million Units)
  • Table 45 Italy Pharmaceutical Glass Packaging Market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
  • Table 46 Italy Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2021 - 2033 (USD Million) (Million Units)
  • Table 47 Italy Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2021 - 2033 (USD Million) (Million Units)
  • Table 48 Italy Pharmaceutical Glass Packaging Market estimates and forecasts, by Drug, 2021 - 2033 (USD Million) (Million Units)
  • Table 49 Spain Pharmaceutical Glass Packaging Market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
  • Table 50 Spain Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2021 - 2033 (USD Million) (Million Units)
  • Table 51 Spain Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2021 - 2033 (USD Million) (Million Units)
  • Table 52 Spain Pharmaceutical Glass Packaging Market estimates and forecasts, by Drug, 2021 - 2033 (USD Million) (Million Units)
  • Table 53 Asia Pacific Pharmaceutical Glass Packaging Market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
  • Table 54 Asia Pacific Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2021 - 2033 (USD Million) (Million Units)
  • Table 55 Asia Pacific Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2021 - 2033 (USD Million) (Million Units)
  • Table 56 Asia Pacific Pharmaceutical Glass Packaging Market estimates and forecasts, by drug, 2021 - 2033 (USD Million) (Million Units)
  • Table 57 China Pharmaceutical Glass Packaging Market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
  • Table 58 China Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2021 - 2033 (Million Units) (Million Units)
  • Table 59 China Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2021 - 2033 (USD Million) (Million Units)
  • Table 60 China Pharmaceutical Glass Packaging Market estimates and forecasts, by drug, 2021 - 2033 (USD Million) (Million Units)
  • Table 61 India Pharmaceutical Glass Packaging Market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
  • Table 62 India Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2021 - 2033 (USD Million) (Million Units)
  • Table 63 India Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2021 - 2033 (USD Million) (Million Units)
  • Table 64 India Pharmaceutical Glass Packaging Market estimates and forecasts, by drug, 2021 - 2033 (USD Million) (Million Units)
  • Table 65 Japan Pharmaceutical Glass Packaging Market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
  • Table 66 Japan Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2021 - 2033 (USD Million) (Million Units)
  • Table 67 Japan Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2021 - 2033 (USD Million) (Million Units)
  • Table 68 Japan Pharmaceutical Glass Packaging Market estimates and forecasts, by drug, 2021 - 2033 (USD Million) (Million Units)
  • Table 69 South Korea Pharmaceutical Glass Packaging Market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
  • Table 70 South Korea Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2021 - 2033 (USD Million) (Million Units)
  • Table 71 South Korea Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2021 - 2033 (USD Million) (Million Units)
  • Table 72 South Korea Pharmaceutical Glass Packaging Market estimates and forecasts, by drug, 2021 - 2033 (USD Million) (Million Units)
  • Table 73 Australia Pharmaceutical Glass Packaging Market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
  • Table 74 Australia Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2021 - 2033 (USD Million) (Million Units)
  • Table 75 Australia Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2021 - 2033 (USD Million) (Million Units)
  • Table 76 Australia Pharmaceutical Glass Packaging Market estimates and forecasts, by drug, 2021 - 2033 (USD Million) (Million Units)
  • Table 77 Central & South America Pharmaceutical Glass Packaging Market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
  • Table 78 Central & South America Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2021 - 2033 (USD Million) (Million Units)
  • Table 79 Central & South America Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2021 - 2033 (USD Million) (Million Units)
  • Table 80 Central & South America Pharmaceutical Glass Packaging Market estimates and forecasts, by drug, 2021 - 2033 (USD Million) (Million Units)
  • Table 81 Brazil Pharmaceutical Glass Packaging Market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
  • Table 82 Brazil Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2021 - 2033 (USD Million) (Million Units)
  • Table 83 Brazil Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2021 - 2033 (USD Million) (Million Units)
  • Table 84 Brazil Pharmaceutical Glass Packaging Market estimates and forecasts, by drug, 2021 - 2033 (USD Million) (Million Units)
  • Table 85 Middle East & Africa Pharmaceutical Glass Packaging Market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
  • Table 86 Middle East & Africa Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2021 - 2033 (USD Million) (Million Units)
  • Table 87 Middle East & Africa Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2021 - 2033 (USD Million) (Million Units)
  • Table 88 Middle East & Africa Pharmaceutical Glass Packaging Market estimates and forecasts, by drug, 2021 - 2033 (USD Million) (Million Units)
  • Table 89 Saudi Arabia Pharmaceutical Glass Packaging Market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
  • Table 90 Saudi Arabia Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2021 - 2033 (USD Million) (Million Units)
  • Table 91 Saudi Arabia Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2021 - 2033 (USD Million) (Million Units)
  • Table 92 Saudi Arabia Pharmaceutical Glass Packaging Market estimates and forecasts, by drug, 2021 - 2033 (USD Million) (Million Units)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Primary research pattern
  • Fig. 3 Primary Research Process
  • Fig. 4 Market research approaches - Bottom-Up Approach
  • Fig. 5 Market research approaches - Top-Down Approach
  • Fig. 6 Market research approaches - Combined Approach
  • Fig. 7 Pharmaceutical Glass Packaging Market- Market Snapshot
  • Fig. 8 Pharmaceutical Glass Packaging Market- Segment Snapshot (1/2)
  • Fig. 9 Pharmaceutical Glass Packaging Market- Segment Snapshot (2/2)
  • Fig. 10 Pharmaceutical Glass Packaging Market- Competitive Landscape Snapshot
  • Fig. 11 Pharmaceutical Glass Packaging Market: Penetration & Growth Prospect Mapping
  • Fig. 12 Pharmaceutical Glass Packaging Market: Value Chain Analysis
  • Fig. 13 Pharmaceutical Glass Packaging Market: Porter's Five Force Analysis
  • Fig. 14 Pharmaceutical Glass Packaging Market: PESTEL Analysis
  • Fig. 15 Pharmaceutical Glass Packaging market: Material movement analysis, 2025 & 2033
  • Fig. 16 Pharmaceutical Glass Packaging market: Product movement analysis, 2025 & 2033
  • Fig. 17 Pharmaceutical Glass Packaging market: Drug movement analysis, 2025 & 2033
  • Fig. 18 Pharmaceutical Glass Packaging market: Regional movement analysis, 2025 & 2033
  • Fig. 19 Pharmaceutical Glass Packaging Market: Competitive Dashboard Analysis